The emergence and spread of carbapenem-resistant (CarR) bacteria are a global problem for treatment of patients all over the world. This type of antimicrobial resistant is particularly danger by cancer patients. Regular monitoring of carbapenem-resistant microorganisms and the determination of the mechanism of their spread will help keep CarR bacteria from spreading This article contains the results of monitoring of carbapenem-resistant strains of microorganisms in the oncological clinic.